532296:BOM
Glenmark Pharmaceuticals Ltd
₹2.250,30
arrow_upward
+0,26%(+5,80) 1D
15 ຕ.ລ., 15 ໂມງ 30 ນາທີ 00 ວິນາທີ GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 532296...
Open
₹2.236,05
High
₹2.289,55
Low
₹2.236,05
Mkt. cap
635,15 ຕື້
Avg. vol.
18,39 ພັນ
Volume
10,74 ພັນ
Dividend
0,22%
Quarterly dividend
₹1,25
Ex-dividend date
3 ຕ.ລ. 2025
P/E ratio
35,34
52-wk high
₹2.536,85
52-wk low
₹1.794,00
EPS
₹63,68
Shares outstanding
0,00
No. of employees
17 ພັນ
Open
₹2.236,05
High
₹2.289,55
Low
₹2.236,05
Mkt. cap
635,15 ຕື້
Avg. vol.
18,39 ພັນ
Volume
10,74 ພັນ
Dividend
0,22%
Quarterly dividend
₹1,25
Ex-dividend date
3 ຕ.ລ. 2025
P/E ratio
35,34
52-wk high
₹2.536,85
52-wk low
₹1.794,00
EPS
₹63,68
Shares outstanding
0,00
No. of employees
17 ພັນ
News stories
From web sources and news partners
Investor's Business Daily
·
1 ຊົ່ວໂມງກ່ອນ
S&P 500 Holds Key Level, AI Off Lows, 12 New Buys. But Beware This.
Business Wire
·
1 ຊົ່ວໂມງກ່ອນ
SITE Centers Announces Plan to De-list from NYSE
TradingView
·
1 ຊົ່ວໂມງກ່ອນ
Independent Bank (NASDAQ:INDB) Posts Better-Than-Expected Sales In Q3 2026
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd